ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Drug Fix: New US FDA Developments In AI Regulation"
Episode Synopsis
Pink Sheet reporter and editors discuss new developments in the FDA’s plans to regulate artificial intelligence and drugs associated with it, including a new AI Council within CDER, as well as some of the unanswered questions about AI in drug development.
More On These Topics From The Pink Sheet Artificial Intelligence:
CDER’s New Council Takes Charge Of Oversight, Coordination: https://pink.citeline.com/PS155173/Artificial-Intelligence-CDERs-New-Council-Takes-Charge-Of-Oversight-Coordination AI In Drug Development: Regulatory Clarity Needed On Inspections, Human Role: https://pink.citeline.com/PS155156/AI-In-Drug-Development-Regulatory-Clarity-Needed-On-Inspections-Human-Role
More On These Topics From The Pink Sheet Artificial Intelligence:
CDER’s New Council Takes Charge Of Oversight, Coordination: https://pink.citeline.com/PS155173/Artificial-Intelligence-CDERs-New-Council-Takes-Charge-Of-Oversight-Coordination AI In Drug Development: Regulatory Clarity Needed On Inspections, Human Role: https://pink.citeline.com/PS155156/AI-In-Drug-Development-Regulatory-Clarity-Needed-On-Inspections-Human-Role
More episodes of the podcast Citeline Podcasts
Datamonitor Healthcare Podcast: ESMO 2025
12/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025
04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
31/10/2025
In God we trust